Gene · 51564
Papers2,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma. | J Enzyme Inhib Med Chem | 2023 | 37096557 | PubTator, text mining | PubMed |
Utilization of mechanical power and associations with clinical outcomes in brain injured patients: a secondary analysis of the extubation strategies in neuro-intensive care unit patients and associations with outcome (ENIO) trial. | Crit Care | 2023 | 37081474 | PubTator, text mining | PubMed |
| Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37080965 | PubTator, text mining | PubMed |
| Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. | Cancer Metastasis Rev | 2023 | 37059907 | PubTator, text mining | PubMed |
| Crosstalk between Gut Microbiota and Epigenetic Markers in Obesity Development: Relationship between Ruminococcus, BMI, and MACROD2/SEL1L2 Methylation. | Nutrients | 2023 | 37049393 | PubTator, text mining | PubMed |
| Pharmacological Targeting of Bcl-2 Induces Caspase 3-Mediated Cleavage of HDAC6 and Regulates the Autophagy Process in Colorectal Cancer. | Int J Mol Sci | 2023 | 37047634 | PubTator, text mining | PubMed |
| Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification. | Int J Mol Sci | 2023 | 37047616 | PubTator, text mining | PubMed |
| Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. | Cancer Gene Ther | 2023 | 37041276 | PubTator, text mining | PubMed |
| Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich's ataxia. | Hum Mol Genet | 2023 | 37027192 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes. | Front Endocrinol (Lausanne) | 2023 | 37008937 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazoles in anticancer drug design and discovery. | Bioorg Chem | 2023 | 36989736 | PubTator, text mining | PubMed |
| Histone Deacetylase 6 Inhibitor CKD-WID Suppressed Monosodium Urate-Induced Osteoclast Formation by Blocking Calcineurin-NFAT Pathway in RAW 264.7 Cells. | Pharmaceuticals (Basel) | 2023 | 36986544 | PubTator, text mining | PubMed |
| Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. | Int J Mol Sci | 2023 | 36982651 | PubTator, text mining | PubMed |
| Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. | Genes (Basel) | 2023 | 36980849 | PubTator, text mining | PubMed |
| New Approaches to Targeting Epigenetic Regulation in Bladder Cancer. | Cancers (Basel) | 2023 | 36980741 | PubTator, text mining | PubMed |
| Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis. | Cancers (Basel) | 2023 | 36980717 | PubTator, text mining | PubMed |
| Epigenetic Targets in Schizophrenia Development and Therapy. | Brain Sci | 2023 | 36979236 | PubTator, text mining | PubMed |
| The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation. | Front Pharmacol | 2023 | 36969848 | PubTator, text mining | PubMed |
| Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer. | Front Immunol | 2023 | 36969235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51564/papers?page=13